RESEARCH PROGRESS IN THE DIAGNOSIS AND TREATMENT OF MULTIPLE MYELOMA
Journal of Pharmaceutical and Medical Research · 13.04.2026 · 8 (2) · 16-20
DOI: 10.61784/jpmr3072 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmaceutical and Medical Research, online erschienen am 13.04.2026. Verfasst von YiFan Ding und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Multiple myeloma (MM) is a hematologic disorder characterized by clonal abnormal proliferation of malignant plasma cells in the bone marrow, accompanied by the presence of monoclonal immunoglobulins or their fragments in the blood and urine. The most important tools for diagnosing MM include molecular diagnosis, bone marrow cytology, and imaging, etc. The early symptoms of MM are atypical and easily misdiagnosed or missed, and need to be combined with several laboratory tests to make a comprehensive judgment. In recent years, research on oncogenesis, cytogenetics and molecular biology has been fruitful, and a variety of biomarkers such as microRNA, circulating tumor cells, circulating free DNA, circulating tumor DNA, etc. have been found to be related to multiple myeloma, which can be used for the auxiliary diagnosis of MM, predicting disease progression or for subsequent therapeutic targets. And with the development of science and technology, artificial intelligence and machine learning can also assist physicians in analysis and diagnosis. Meanwhile, monoclonal antibody therapies, targeting B-cell maturation antigens, etc. have also been shown to have better clinical efficacy in the treatment of multiple myeloma. The purpose of this article is to review the laboratory tests that are important for the diagnosis of multiple myeloma and the treatment options for the disease, to provide a basis and direction for the clinical diagnosis and treatment of multiple myeloma, and to improve the detection rate and efficacy of multiple myeloma.
Zitieren
APA
Ding, Y., & Xiao, H. (2026). RESEARCH PROGRESS IN THE DIAGNOSIS AND TREATMENT OF MULTIPLE MYELOMA. Journal of Pharmaceutical and Medical Research, 8(2), 16-20. https://doi.org/10.61784/jpmr3072
Vancouver
Ding Y, Xiao H. RESEARCH PROGRESS IN THE DIAGNOSIS AND TREATMENT OF MULTIPLE MYELOMA. Journal of Pharmaceutical and Medical Research. 2026;8(2):16-20. doi:10.61784/jpmr3072
BibTeX
@article{Ding2026,
author = {Ding, YiFan and Xiao, Hu},
title = {RESEARCH PROGRESS IN THE DIAGNOSIS AND TREATMENT OF MULTIPLE MYELOMA},
journal = {Journal of Pharmaceutical and Medical Research},
year = {2026},
volume = {8},
number = {2},
pages = {16--20},
doi = {10.61784/jpmr3072}
}
EUVIMED